Clinical trial
MDSC Clinical Assay for Cancer Detection and Monitoring in Renal Cell Carcinoma
NCT02664883 is registered in ClinicalTrials.gov with University of Southern California as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- MDSC Clinical Assay for Cancer Detection and Monitoring in Renal Cell Carcinoma
- Lead sponsor
- University of Southern California
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- September 8, 2015
- Completion date
- October 29, 2026
- Enrollment
- 37 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
healthy subject, metastatic renal cell cancer, recurrent renal cell carcinoma, stage i renal cell cancer, stage ii renal cell cancer, stage iii renal cell cancer